Therapeutic vignette: Old and new drugs in mixed connective tissue disease

Israel Medical Association Journal

Volumn 10, Issue 11, 2008, Pages 831-832

  Rozenbaum, Michael ^a,c   Slobodin, Gleb ^a,c   Boulman, Nina ^a,c   Feld, Joy ^a,c   Avshovich, Nina ^a,c   Ben Arieh, Yehudit ^b,c   Rosner, Itzhak ^a,c  

^a BNAI ZION MEDICAL CENTER   (Israel)

^b RAMBAM MEDICAL CENTER   (Israel)

^c TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Anti tumor necrosis factor; Lymphoma; Mixed connective tissue disease; Potassium iodide

Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; CILAZAPRIL; CORTICOSTEROID; FOLIC ACID; HYDROXYCHLOROQUINE; ILOPROST; INFLIXIMAB; METHOTREXATE; METHYLPREDNISOLONE; NEW DRUG; POTASSIUM IODIDE; PREDNISONE; STEROID; ANTIRHEUMATIC AGENT; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DISEASE COURSE; DISEASE EXACERBATION; DOPPLER ECHOCARDIOGRAPHY; DRUG MEGADOSE; DRUG RESPONSE; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; HUMAN; LABORATORY TEST; LOW DRUG DOSE; LYMPHOMA; MALE; MIXED CONNECTIVE TISSUE DISEASE; NECROTIZING ARTERITIS; OUTCOME ASSESSMENT; RAYNAUD PHENOMENON; THORAX RADIOGRAPHY; CHEMICALLY INDUCED DISORDER; COMORBIDITY; DRUG ANTAGONISM; DRUG COMBINATION; FATALITY; LARGE CELL LYMPHOMA; MIDDLE AGED; SKIN ULCER; VASCULITIS;

ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; COMORBIDITY; DISEASE PROGRESSION; DRUG THERAPY, COMBINATION; FATAL OUTCOME; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; METHOTREXATE; MIDDLE AGED; MIXED CONNECTIVE TISSUE DISEASE; POTASSIUM IODIDE; PREDNISONE; SKIN ULCER; TUMOR NECROSIS FACTOR-ALPHA; VASCULITIS;

EID: 58149331220     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weissman MH, Rheumatology. 3rd edn. New York: Mosby, 2003.
2. Sterling JB, Heyman WR. Potassium iodide in dermatology: a 19th century drug for 21st century-uses: pharmacology, adverse effects, and contraindications. J Am Acad Dermatol 2000;43:691-7.
3. Burdt MA, Hoffman RW, Deutsher SL, Wang GS, Johnson JC, Sharp GC. Long term outcome in mixed connective tissue disease. Arthritis Rheum 1999;42:899-909.
4. Avraham Z, Rozenbaum M, Portnoy E, Rosner I. Severe livedo vasculitis treated with potassium iodide. Rheumatol Int 2003;2:96-8.
5. Wolfe F, Michaud K. The effect of methotrexate and anti-tumor necrosis factor therapy on the risk of lymphoma in rheumatoid arthritis in 19,562 patients during 89,710 person-years of observation. Arthritis Rheum 2007;56:1433-9.